Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Viekira Pak
Viekira Pak
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
Investors Business Daily
Wed, 07/19/17 - 07:55 pm
AbbVie
Gilead Sciences
hepatitis C
Vosevi
Harvoni
Sovaldi
Epclusa
Viekira Pak
3 Biggest Risks for AbbVie in 2017
Motley Fool
Wed, 12/28/16 - 11:03 am
AbbVie
Humira
biosimilars
Imbruvica
Viekira Pak
Elagolix
risankizumab
3 Things AbbVie's Management Said While Its Stock Got Hammered
Motley Fool
Sat, 10/29/16 - 01:23 pm
AbbVie
earnings
Humira
Imbruvica
Viekira Pak
AbbVie's Viekira Pak Sales Plummet in Q3
Motley Fool
Fri, 10/28/16 - 05:22 pm
AbbVie
Viekira Pak
eanrings
AbbVie Inc: New Drugs May Overcome Humira Loss
Bidness, ETC
Mon, 08/1/16 - 03:56 pm
AbbVie
Humira
Rova-T
Venclexta
Imbruvica
Viekira Pak
AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis
Yahoo
Mon, 04/25/16 - 06:39 pm
AbbVie
FDA
Viekira Pak
hepatitis C
Will Merck Encroach On Gilead's Harvoni Territory?
Yahoo/Benzinga
Tue, 02/23/16 - 05:44 pm
Merck
Gilead
Harvoni
AbbVie
hepatitis C
Viekira Pak
Zepatier
Harvoni’s New Label Gives Gilead Edge Over AbbVie
Bidness, ETC
Wed, 02/17/16 - 10:42 am
Harvoni
labeling
Gilead Sciences
AbbVie
Viekira Pak
hepatitis C
3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next
Motley Fool
Tue, 01/19/16 - 04:24 pm
AbbVie
Humira
Imbruvica
Viekira Pak
AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15
Yahoo/Market Realist
Tue, 01/19/16 - 09:28 am
AbbVie
hepatitis C
Lupron
Duodopa
Creon
Viekira Pak
AbbVie's Management Just Made Some Pretty Bold Predictions
Motley Fool
Sun, 01/17/16 - 12:18 pm
AbbVie
Humira
Viekira Pak
Gilead Faces Troubled HCV Scripts as AbbVie Scripts Go Up
Bidness, ETC
Wed, 12/30/15 - 07:07 pm
Gilead Sciences
AbbVie
hepatitis C
Sovaldi
Harvoni
Viekira Pak
Is Merck & Co. About to Derail Gilead Sciences?
Motley Fool
Tue, 12/22/15 - 09:59 pm
Merck
Gilead Sciences
grazoprevir/elbasvir
Viekira Pak
AbbVie
AbbVie Announces FDA Acceptance of New Drug Application for a Once-Daily Formulation of VIEKIRA PAK to Treat Genotype 1 Chronic Hepatitis C Virus Infection
Yahoo
Wed, 12/2/15 - 09:28 am
AbbVie
hepatitis C
Viekira Pak
AbbVie Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis
Yahoo
Sat, 11/14/15 - 11:33 am
AbbVie
Viekira Pak
hepatitis C
Express Scripts to maintain availability of AbbVie's hep C drug
Yahoo/Reuters
Wed, 10/28/15 - 02:58 pm
Express Scripts
AbbVie
hepatitis C
Viekira Pak
FDA's Warning Shakes Up Hep C Landscape
Investopedia
Fri, 10/23/15 - 05:08 pm
FDA
warnings
hepatitis C
AbbVie
Gilead Sciences
Harvoni
Viekira Pak
How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead
24/7 Wall St
Fri, 10/23/15 - 11:08 am
FDA
Gilead Sciences
AbbVie
hepatitis C
warnings
Viekira Pak
Technivie
FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10%
Fierce Pharma
Thu, 10/22/15 - 07:30 pm
FDA
hepatitis C
AbbVie
liver damage
Technivie
Viekira Pak
Is Gilead Sciences' Dominance in Hepatitis C Unstoppable?
Motley Fool
Tue, 09/29/15 - 09:04 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
AbbVie
Viekira Pak
Achillion
Pages
1
2
3
next ›
last »